SW-682 is an investigational novel, oral, potent, and selective pan-TEAD inhibitor and patients are being enrolled in a Phase 1a trial in Hippo-mutant solid tumors. In July, SpringWorks appointed ...
Jacob Gaylord ran for three second-half touchdowns and rallied Gravette past Gentry in a 4A-1 Conference showdown between western Benton County teams at Lion Stadium in Gravette.
Achieved $49.3 million in OGSIVEO® (nirogacestat) net product revenue in the third quarter - - Long-term follow-up data from the Phase 3 DeFi trial of nirogacestat in adults with desmoid tumors highli ...
Since I started speaking out about the attack on our family shelter, St. Anne’s Place, and the police’s substandard response, much of the conversation has naturally turned to policing. But that’s not ...